Tokyo Relife Clinic is a premier regenerative medicine clinic in the heart of Ginza, Tokyo, specializing in autologous adipose-derived stem cell therapy. Licensed under Japan's Act on the Safety of Regenerative Medicine, the clinic holds 9 Ministry-approved treatment plans — one of the most comprehensive regenerative medicine portfolios in Japan.
Tokyo Relife integrates an in-house cell culture facility with clinical research capabilities, enabling evidence-based, personalized treatment for a wide range of chronic and age-related conditions. Stem cell treatments use the patient’s own cells, minimizing the risk of rejection, and are paired with epigenetic clock testing to objectively measure biological age before and after treatment.
Why Tokyo Relife? Tokyo Relife combines advanced cell-based therapies with in-house laboratory capabilities and research-driven care. Its in-house Cell Processing Center (CPC) handles cell collection, culture, quality control, and administration without outsourcing. The clinic uses xeno-free culture methods with 24/7 monitoring, while fresh cells are administered directly from the in-house laboratory at peak activity without freezing or transportation. Each cell undergoes gene-level quality checks before administration.
Tokyo Relife also offers epigenetic clock testing to assess biological age before and after treatment. Its research initiatives include a joint program with The University of Tokyo, Graduate School of Science, focused on “Cellular Senescence Control.” In addition, TRC serves as the clinical partner of Goda Lab in the XPRIZE Healthspan competition, a research team led by The University of Tokyo in collaboration with Tohoku University and NanoTitan, which was named one of the Top 10 Finalists among 600+ teams worldwide in September 2026.
Located across floors 6–8 of the Toraya Ginza Building, Tokyo Relife also features a dedicated VIP floor, providing a specialized setting for patients seeking advanced regenerative and longevity-focused care.
VIP Patient Experience
